Location: Rockville,MD, USA
Hansoh Bio
A U.S.-based research & development subsidiary of Hansoh Pharma, Hansoh Bio is a biotech devoted to discovering and developing breakthrough therapies that conquer serious diseases and disorders for patients around the world. Hansoh Pharma is a leading biopharmaceutical company in Asia. Founded in 1995, we are committed to discovering and developing life-changing medicines to help patients. Our rapidly growing workforce of 9,000+ employees, and our fully integrated research and development, manufacturing and commercial capabilities have propelled us into leadership positions across a broad range of therapeutic areas, including CNS, oncology, infectious disease, and metabolic disorders. With 1,400 professionals across multiple R&D functions, we rank 2nd in innovation among all Chinese biotech and pharmaceutical companies, based on new molecular entities developed for clinical development. Since an IPO on Hong Kong stock exchange in June 2019, we have raised $1.6B from global top-tier institutional investors; with a current equity value of approximately $27B, Hansoh is the 2nd largest biopharmaceutical companies in China and 6th largest in Asia by market capitalization. For more information, please visit www.hspharm.com.
Responsibilities
Qualifications
Company provides competitive compensation with health, dental and vision coverage, as well as a matching 401K retirement plan.
Hansoh Bio is an Equal Opportunity Employer. Hansoh does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, national origin, veteran status, or any other status protected under federal, state, or local law.